197 related articles for article (PubMed ID: 27376428)
1. Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio?
Yazici P; Mihmanli M; Bozkurt E; Ozturk FY; Uludag M
Hormones (Athens); 2016 Apr; 15(2):256-263. PubMed ID: 27376428
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer.
Sands NB; Karls S; Rivera J; Tamilia M; Hier MP; Black MJ; Gologan O; Payne RJ
J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):669-73. PubMed ID: 21144363
[TBL] [Abstract][Full Text] [Related]
4. Preoperative TSH and thyroglobulin levels: would it predict thyroid cancer?
Al-Bader A; Zawawi F; Singer Z; Mlynarek A; Hier M; Tamilia M; Payne R
Otolaryngol Pol; 2015; 69(3):21-5. PubMed ID: 26388246
[TBL] [Abstract][Full Text] [Related]
5. Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.
Hulikal N; Re A; Banoth M; Chowhan AK; Yutla M; Sachan A
Acta Otorhinolaryngol Ital; 2020 Feb; 40(1):33-37. PubMed ID: 32275647
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.
Rinaldi S; Plummer M; Biessy C; Tsilidis KK; Østergaard JN; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Clavel-Chapelon F; Dossus L; Kaaks R; Lukanova A; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Lund E; Quirós JR; Agudo A; Molina E; Larrañaga N; Navarro C; Ardanaz E; Manjer J; Almquist M; Sandström M; Hennings J; Khaw KT; Schmidt J; Travis RC; Byrnes G; Scalbert A; Romieu I; Gunter M; Riboli E; Franceschi S
J Natl Cancer Inst; 2014 Jun; 106(6):dju097. PubMed ID: 24824312
[TBL] [Abstract][Full Text] [Related]
8. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
Zhao T; Liang J; Guo Z; Li J; Lin Y
Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.
Moon JH; Kim YI; Lim JA; Choi HS; Cho SW; Kim KW; Park HJ; Paeng JC; Park YJ; Yi KH; Park DJ; Kim SE; Chung JK
J Clin Endocrinol Metab; 2013 Mar; 98(3):1061-8. PubMed ID: 23393171
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.
Lin Y; Li T; Liang J; Li X; Qiu L; Wang S; Chen Y; Kang Z; Li F
Clin Nucl Med; 2011 Dec; 36(12):1102-5. PubMed ID: 22064080
[TBL] [Abstract][Full Text] [Related]
11. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
12. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
13. Lymph node fine-needle aspiration washout thyroglobulin in papillary thyroid cancer: Diagnostic value and the effect of thyroglobulin antibodies.
Konca Degertekin C; Yalcin MM; Cerit T; Ozkan C; Kalan I; Iyidir OT; Altinova AE; Akturk M; Toruner F; Akin M; Cakir N
Endocr Res; 2016 Nov; 41(4):281-289. PubMed ID: 26905960
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Serum Thyroglobulin Level as a Useful Predictive Marker to Differentiate Thyroid Cancer.
Kars A; Aktan B; Kilic K; Sakat MS; Gözeler MS; Yörük Ö; Mutlu V; Yılmaz S
ORL J Otorhinolaryngol Relat Spec; 2018; 80(5-6):290-295. PubMed ID: 30253396
[TBL] [Abstract][Full Text] [Related]
15. Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?
Tian T; Huang R; Liu B
Endocrine; 2019 Jul; 65(1):149-154. PubMed ID: 30924085
[TBL] [Abstract][Full Text] [Related]
16. Value of serial preablative thyroglobulin measurements: can we address the impact of thyroid remnants?
Zhao T; Liang J; Li T; Guo Z; Vinjamuri S; Lin Y
Nucl Med Commun; 2016 Jun; 37(6):632-9. PubMed ID: 26829063
[TBL] [Abstract][Full Text] [Related]
17. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
[TBL] [Abstract][Full Text] [Related]
18. In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation.
Angell TE; Spencer CA; Rubino BD; Nicoloff JT; LoPresti JS
Thyroid; 2014 Jul; 24(7):1127-33. PubMed ID: 24697314
[TBL] [Abstract][Full Text] [Related]
19. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
Kloos RT; Mazzaferri EL
J Clin Endocrinol Metab; 2005 Sep; 90(9):5047-57. PubMed ID: 15972576
[TBL] [Abstract][Full Text] [Related]
20. In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin.
Valle LA; Gorodeski Baskin RL; Porter K; Sipos JA; Khawaja R; Ringel MD; Kloos RT
Thyroid; 2013 Feb; 23(2):185-93. PubMed ID: 22978687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
